Current through Register Vol. 63, No. 11, November 1, 2024
Section 332-026-0020 - Approved Legend Drugs For Neonatal UseAn LDM may administer the following legend drugs as approved by the Board for neonatal use:
(1) Eye Prophylaxis for disease of the newborn is limited to Erythromycin Ophthalmic (0.5%) Ointment (Ilotycin, AK-Mycin and generics).(2) Prophylaxis for hemorrhagic disease of the newborn for oral use is limited to Mephyton.(3) Prophylaxis for hemorrhagic disease of the newborn for intramuscular injection includes: (4) Resuscitation is limited to medical oxygen.Or. Admin. Code § 332-026-0020
DEM 1-2001(Temp), f. & cert. ef. 10-1-01 thru 3-29-02; DEM 1-2002, f. 2-25-02 cert. ef. 3-1-02; DEM 1-2004, f. 6-29-04, cert. ef. 7-1-04; DEM 6-2010, f. 12-30-10, cert. ef. 1-1-11; Renumbered from 332-025-0050 by DEM 5-2011, f. & cert. ef. 9-26-11; DEM 3-2019, amend filed 12/19/2019, effective 1/1/2020Statutory/Other Authority: ORS 676.615 & ORS 687.493
Statutes/Other Implemented: ORS 687.493